UM

Browse/Search Results:  1-10 of 376 Help

Selected(0)Clear Items/Page:    Sort:
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 Journal article
Lau, George, Obi, Shuntaro, Zhou, Jian, Tateishi, Ryosuke, Qin, Shukui, Zhao, Haitao, Otsuka, Motoyuki, Ogasawara, Sadahisa, George, Jacob, Chow, Pierce K.H., Cai, Jianqiang, Shiina, Shuichiro, Kato, Naoya, Yokosuka, Osamu, Oura, Kyoko, Yau, Thomas, Chan, Stephen L., Kuang, Ming, Ueno, Yoshiyuki, Chen, Minshan, Cheng, Ann Lii, Cheng, Gregory, Chuang, Wan Long, Baatarkhuu, Oidov, Bi, Feng, Dan, Yock Young, Gani, Rino A., Tanaka, Atsushi, Jafri, Wasim, Jia, Ji Dong, Kao, Jia Horng, Hasegawa, Kiyoshi, Lau, Patrick, Lee, Jeong Min, Liang, Jun, Liu, Zhenwen, Lu, Yinying, Pan, Hongming, Payawal, Diana A., Rahman, Salimur, Seong, Jinsil, Shen, Feng, Shiha, Gamal, Song, Tianqiang, Sun, Hui Chuan, Masaki, Tsutomu, Sirachainan, Ekaphop, Wei, Lai, Yang, Jin Mo, Sallano, Jose D., Zhang, Yanqiao, Tanwandee, Tawesak, Dokmeci, AKadir, Zheng, Shu Sen, fan, Jia, Fan, Sheung Tat, Sarin, Shiv Kumar, Omata, Masao. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024[J]. Hepatology International, 2024, 18(6), 1661-1683.
Authors:  Lau, George;  Obi, Shuntaro;  Zhou, Jian;  Tateishi, Ryosuke;  Qin, Shukui; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:5.9/6.6 | Submit date:2024/12/05
Hepatocellular Carcinoma  Systemic Therapy  Guidelines  The Asian Pacific Association For The Study Of The Liver  
Polycyclic polyprenylated acylphloroglucinols from the pericarps of Garcinia multiflora champ. ex Benth. with cytotoxic property Journal article
Cao, Jun, Lyu, Wen Yu, Zhang, Yujia, Su, Zhicheng, Li, Ting, Zhang, Qingwen, Gan, Lishe, Lu, Jin Jian, Lin, Ligen. Polycyclic polyprenylated acylphloroglucinols from the pericarps of Garcinia multiflora champ. ex Benth. with cytotoxic property[J]. Phytochemistry, 2024, 228, 114242.
Authors:  Cao, Jun;  Lyu, Wen Yu;  Zhang, Yujia;  Su, Zhicheng;  Li, Ting; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.2/3.4 | Submit date:2024/09/03
Apoptosis  Cell Cycle Arrest  Clusiaceae  Cytotoxicity  Garcinia Multiflora  Polycyclic Polyprenylated Acylphloroglucinols  
Uncover the anticancer potential of lycorine Journal article
Zhang, Yan Ming, Li, Ting, Xu, Chun Cao, Qian, Jia Yu, Guo, Hongwei, Zhang, Xiaolei, Zhan, Zha Jun, Lu, Jin Jian. Uncover the anticancer potential of lycorine[J]. Chinese Medicine (United Kingdom), 2024, 19(1), 121.
Authors:  Zhang, Yan Ming;  Li, Ting;  Xu, Chun Cao;  Qian, Jia Yu;  Guo, Hongwei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2 | Submit date:2024/10/10
Anticancer Mechanism  Lycorine  Lycorine Hydrochloride  Pharmacokinetics  Target  
Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis Journal article
Li, Yue Kang, Ge, Fu Jing, Liu, Xiang Ning, Zeng, Chen Ming, Qian, Mei Jia, Li, Yong Hao, Zheng, Ming Ming, Qu, Jing Jing, Fang, Liang Jie, Lu, Jin Jian, Yang, Bo, He, Qiao Jun, Zhou, Jian Ya, Zhu, Hong. Ivacaftor, a CFTR potentiator, synergizes with osimertinib against acquired resistance to osimertinib in NSCLC by regulating CFTR-PTEN-AKT axis[J]. Acta Pharmacologica Sinica, 2024.
Authors:  Li, Yue Kang;  Ge, Fu Jing;  Liu, Xiang Ning;  Zeng, Chen Ming;  Qian, Mei Jia; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:6.9/7.6 | Submit date:2024/12/26
Acquired Resistance  Cftr  Ivacaftor  Nsclc  Osimertinib  
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products Journal article
Zhang, Le Le, Zhang, Du Juan, Shi, Jia Xin, Huang, Mu Yang, Yu, Jia Mei, Chen, Xu Jia, Wei, Xiao, Zou, Liang, Lu, Jin Jian. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products[J]. Phytomedicine, 2024, 132, 155828.
Authors:  Zhang, Le Le;  Zhang, Du Juan;  Shi, Jia Xin;  Huang, Mu Yang;  Yu, Jia Mei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:6.7/6.2 | Submit date:2024/07/04
Immunogenic Cell Death  Regulated Cell Death  Natural Products  Cancer Therapy  Tumor Immune Microenvironment  
Cancer statistics and trends in China: the potential of natural product application Other
2024-08-01
Authors:  LI, Ting;  HUANG, Muyang;  LU, Jinjian
Favorite | TC[WOS]:0 TC[Scopus]:1 | Submit date:2024/10/10
Cancer Incidence  Increasing Trends  Mortality  Natural Products  
Anticancer research of natural products from traditional Chinese medicine: Current situation and prospect Presentation
报告日期: 2024-07-01
Authors:  LU JINJIAN
Favorite |  | Submit date:2024/08/23
Anticancer research of natural products from traditional Chinese medicine: Current situation and prospect Presentation
报告日期: 2024-07-01
Authors:  LU JINJIAN
Favorite |  | Submit date:2024/08/23
Anticancer research of natural products: Current situation and prospect Presentation
报告日期: 2024-05-01
Authors:  LU JINJIAN
Favorite |  | Submit date:2024/08/23
Upregulation of Nrf2 signaling: A key molecular mechanism of Baicalin's neuroprotective action against diabetes-induced cognitive impairment Journal article
Zheng, Yanfang, Wang, Chenxiang, Liu, Wenjing, Chen, Jiaying, Sun, Yibin, Chang, Dennis, Wang, Huan, Xu, Wen, Lu, Jin Jian, Zhou, Xian, Huang, Mingqing. Upregulation of Nrf2 signaling: A key molecular mechanism of Baicalin's neuroprotective action against diabetes-induced cognitive impairment[J]. Biomedicine and Pharmacotherapy, 2024, 174, 116579.
Authors:  Zheng, Yanfang;  Wang, Chenxiang;  Liu, Wenjing;  Chen, Jiaying;  Sun, Yibin; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:6.9/6.8 | Submit date:2024/05/16
Baicalin  Diabetes-associated Cognitive Deficits  Keap1-nrf2  Neuroinflammation  Nlrp3 Inflammasome  Oxidative Stress